Skip to content
ClinCalc Pro
Menu
IV Induction and Maintenance Agent

Propofol

Brand names: Diprivan

Propofol is a short-acting intravenous anaesthetic agent used for induction and maintenance of general anaesthesia and for procedural sedation.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Propofol potentiates inhibitory GABA-A receptor activity in the central nervous system, producing rapid loss of consciousness with a swift, clear-headed recovery.

Prescribing in practice

  • Propofol causes dose-dependent cardiorespiratory depression including hypotension and apnoea — it must only be given by those trained in anaesthesia and airway management, with full resuscitation and monitoring equipment immediately available.
  • Strict asepsis is essential as the lipid emulsion supports microbial growth; pain on injection is common, and prolonged high-dose infusion risks propofol infusion syndrome.
  • Use with caution and reduced dosing in the elderly, hypovolaemic or haemodynamically unstable patient, and note the emulsion contains soya and egg-derived constituents.

Monitoring

Continuously monitor depth of anaesthesia, oxygenation, ventilation and haemodynamics, and observe for metabolic acidosis during prolonged infusions.

Counselling the patient

  • This is the medicine that sends you off to sleep for your operation, working within seconds.
  • You may feel a brief stinging as it goes into the vein.
  • Recovery is usually quick and clear-headed.

Evidence & guidelines

Propofol is a standard, extensively validated intravenous induction and maintenance agent in modern anaesthesia.

Reference: AAGBI Safety Guidelines; Diprivan SPC; Vasile et al. (PRIS Review); Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.